Corporate taxation has become an important issue in the U.S., as budget deficits loom and an important election approaches. Many U.S. companies have said that high corporate income tax is onerous and reduces their ability to compete globally.
Photo courtesy of Raw Pixel (Unsplash.com)
According to USA Today analysis of S&P Capital IQ data, however, there were at least 20 companies in the Standard & Poor’s 500 that reported paying an effective tax rate of 0 percent or lower for the second quarter of 2014. To be included in the analysis, the companies had to report positive earnings, including unusual items, before taxes.
One such company was drug-producing giant Merck, which had a negative effective tax rate of 7.5 percent for the second quarter, according to USA Today. In other words, taxpayers gave the company the equivalent of 7.5 percent of its quarterly profits in tax credits. Merck’s pre-tax income rose 52 percent during the quarter, coming to $1.9 billion.
This anomalous tax rate was attributed to the “beneficial impact of foreign earnings” in the company’s filing, but Merck also got a significant one-time tax benefit from an option exercise that involved AstraZeneca’s purchase of its interest in a partnership, the news source explained. AstraZeneca has also been under public scrutiny with regards to corporate tax practices.
President Barack Obama and other liberals have been making corporate taxation a major issue ahead of the 2014 midterm elections. Both sides of Congress agree that tax code reform is necessary, but many analysts agree that the political deadlock will prevent anything from happening before the elections determine the shape of the next two years.
As tax attorneys for Scarinci Hollenbeck, a regional business law firm with offices in New York, New Jersey, and Washington D.C., James F. McDonough and I are acclimated with corporate culture and the goings-on of corporations regarding income taxes. Check out some of latest post on this hot-button topic:
A Whistleblower Just Filed a Complaint Against Your Company: Here's What to Do Now
Few situations create more uncertainty than learning that an employee has filed a whistleblower complaint. Questions arise immediately: Is the allegation legitimate? Should the employee be placed on leave? Do we need to notify our insurance carrier? Are we now prevented from disciplining the employee if there are unrelated ongoing work related issues? There is […]
Assignment for the Benefit of Creditors: An Alternative to Bankruptcy for Distressed Businesses
When a business reaches the point where it can no longer service its debts or otherwise resolve its liabilities, management is often faced with a difficult question: is a bankruptcy filing necessary or is there another way to perform an orderly liquidation or sale of the business assets? While Chapters 7 and 11 of the […]
Breaking Down New Jersey’s “Mansion” Tax: What Buyers and Sellers Need to Know
For many years, the New Jersey Mansion Tax has been a significant consideration in high-value real estate transactions. Recent legislative changes, however, have substantially altered how the tax operates, including who is responsible for paying it and the amount owed in certain transactions. Whether you are purchasing, selling, or investing in New Jersey real estate, […]
Estate Planning for Digital Assets Under New Jersey Law
As our personal and financial lives increasingly move online, estate planning must evolve to address a new category of property: digital assets. From email accounts and social media profiles to cryptocurrency and cloud-stored business records, these assets often carry both financial and sentimental value. Yet, without proper planning, they can become inaccessible—or even lost—upon incapacity […]
The Role of Representation and Warranty Insurance in M&A Transactions
In today’s mergers and acquisitions market, representation and warranty (R&W) insurance has become a common feature of deal negotiations. Once used primarily in larger transactions, R&W insurance is now frequently incorporated into middle-market deals as buyers and sellers look for efficient ways to allocate risk and close deals. When structured properly, R&W insurance can help […]
You Just Received a Federal Grand Jury Subpoena in New Jersey: Now What?
Receiving a federal grand jury subpoena is not something most businesses or individuals anticipate. While it can be concerning, a federal grand jury subpoena does not necessarily mean that you are being accused of wrongdoing. It does, however, mean that a federal criminal investigation is underway and that federal prosecutors believe you may possess information […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!
